Akums Drugs and Pharmaceuticals Ltd., a leading name in the pharmaceutical industry, has signed an exclusive Master Sales Agreement with South Korea’s Caregen Co., Ltd. This partnership grants Akums exclusive rights to market and sell Caregen’s innovative nutraceutical products in India.
Caregen, a global leader in peptide research and biotechnology, is renowned for its patented peptides used in diverse health and wellness solutions. Under this agreement, the firm will package, market and sell Caregen’s bulk product product under the Caregen trademark, Akums trademark, or Akums’ Clients trademark.
This collaboration highlights Akums’ commitment to bringing world-class nutraceutical innovations to the Indian market, reinforcing its position as a trusted healthcare solutions provider.
